What We Got Wrong About GLP-1s (And What's Right) | Dr. Tyna Moore

Metabolic health serves as the foundational pillar for overall well-being, with GLP-1 receptor agonists acting as potent tools when integrated into a comprehensive lifestyle strategy. Rather than relying on high-dose monotherapy, which often triggers adverse effects like muscle loss, anhedonia, and gastrointestinal distress, the focus should shift toward individualized, low-dose protocols. These peptides, when used correctly, offer significant benefits beyond weight loss, including improved insulin signaling, reduced inflammation, and potential neuroprotective effects against addiction. However, the current landscape of telehealth prescribing often bypasses necessary medical oversight, leading to improper dosing and patient harm. Success requires a commitment to strength training, adequate protein intake, and consistent monitoring of metabolic markers like fasting insulin. Ultimately, these compounds function best as an assist to, rather than a replacement for, fundamental lifestyle interventions that address the root causes of metabolic dysfunction.